Bio-Path Holdings to Announce Second Quarter 2022 Financial Results on August 16, 2022
HOUSTON, Aug. 09, 2022 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize®...
Bio-Path Holdings Reports First Quarter 2022 Financial Results
Conference Call to be Held Today at 8:30 A.M. ET...
Bio-Path Holdings to Announce First Quarter 2022 Financial Results on May 17, 2022
HOUSTON, May 10, 2022 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH) a biotechnology company leveraging its proprietary DNAbilize® antisense...
Bio-Path Holdings Presents BP1003 Data at 2022 American Association for Cancer Research Annual Meeting
Preclinical Data Support BP1003 Combination Therapy to Treat Breast and Ovarian Cancers...
Bio-Path Holdings Reports Full Year 2021 Financial Results
Conference Call to be Held Today at 8:30 A.M. ET...
Bio-Path Holdings to Present at the 2022 American Association for Cancer Research Annual Meeting
HOUSTON, March 08, 2022 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilizeâ„¢...